Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Visible Genetics close to offering POC genotyping system

This article was originally published in Clinica

Executive Summary

There are two million HIV viral load tests conducted each year in the US to monitor the progress of drug therapy. The mean time between a major component of that drug therapy being adjusted by a physician is just six months. There are some 350,000 patients on triple drug therapy and of those newly presenting, an average of 25% have resistance to some of the commonly used drugs.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073070

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel